- Home
- PUMP vs CSTL Comparison
PUMP vs CSTL Comparison
Compare PUMP & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- CSTL
- Stock Information
- Founded
- PUMP 2007
- CSTL 2007
- Country
- PUMP United States
- CSTL United States
- Employees
- PUMP N/A
- CSTL N/A
- Industry
- PUMP Oilfield Services/Equipment
- CSTL Medical Specialities
- Sector
- PUMP Energy
- CSTL Health Care
- Exchange
- PUMP Nasdaq
- CSTL Nasdaq
- Market Cap
- PUMP 550.9M
- CSTL 568.2M
- IPO Year
- PUMP 2017
- CSTL 2019
- Fundamental
- Price
- PUMP $5.42
- CSTL $21.51
- Analyst Decision
- PUMP Buy
- CSTL Strong Buy
- Analyst Count
- PUMP 6
- CSTL 6
- Target Price
- PUMP $11.20
- CSTL $40.00
- AVG Volume (30 Days)
- PUMP 1.8M
- CSTL 330.2K
- Earning Date
- PUMP 04-29-2025
- CSTL 05-05-2025
- Dividend Yield
- PUMP N/A
- CSTL N/A
- EPS Growth
- PUMP N/A
- CSTL N/A
- EPS
- PUMP N/A
- CSTL 0.62
- Revenue
- PUMP $1,444,286,000.00
- CSTL $332,069,000.00
- Revenue This Year
- PUMP $0.26
- CSTL N/A
- Revenue Next Year
- PUMP $10.08
- CSTL $3.34
- P/E Ratio
- PUMP N/A
- CSTL $34.69
- Revenue Growth
- PUMP N/A
- CSTL 51.09
- 52 Week Low
- PUMP $4.61
- CSTL $16.97
- 52 Week High
- PUMP $11.17
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- PUMP 37.49
- CSTL 56.26
- Support Level
- PUMP $4.75
- CSTL $18.03
- Resistance Level
- PUMP $5.74
- CSTL $20.77
- Average True Range (ATR)
- PUMP 0.49
- CSTL 1.27
- MACD
- PUMP -0.04
- CSTL 0.41
- Stochastic Oscillator
- PUMP 26.91
- CSTL 93.06
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.